Using middle cerebral artery peak systolic velocity to time in utero transfusions in fetomaternal hemorrhage.
BACKGROUND
Fetomaternal hemorrhage is a rare cause of fetal anemia and hydrops fetalis. Early and severe fetomaternal hemorrhage may benefit from in utero transfusion(s); however, hemorrhage rate is unpredictable, and reliable criteria are needed to identify recurrent anemia.


METHODS
Fetal hydrops due to massive fetomaternal hemorrhage was diagnosed at 29 weeks. After the first in utero transfusion, daily monitoring of middle cerebral artery peak systolic velocity suggested recurrent fetal anemia, requiring two additional in utero transfusions at 1-week intervals. One day after the third in utero transfusion, a sudden increase in fetomaternal hemorrhage rate was suspected on a rapid elevation of middle cerebral artery peak systolic velocity, leading to immediate delivery at 32 weeks.


CONCLUSIONS
Middle cerebral artery peak systolic velocity is a relevant, noninvasive tool for the timing of repeated in utero transfusions and of fetal delivery in case of chronic fetomaternal hemorrhage.
Friszer
Stéphanie
S
From the Department of Obstetrics and Gynecology and the Centre National de Référence en Hémobiologie Périnatale, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris; and the Service de Gynécologie Obstétrique, Centre Hospitalo-Universitaire de Poitiers, Université de Poitiers, Poitiers, France.
Cortey
Anne
A
Pierre
Fabrice
F
Carbonne
Bruno
B
D000328:Adult; D001783:Blood Flow Velocity; D001803:Blood Transfusion; D002908:Chronic Disease; D005260:Female; D005331:Fetomaternal Transfusion / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D015160:Hydrops Fetalis / Q000000981:diagnostic imaging / Q000209:etiology; D020768:Middle Cerebral Artery / Q000503:physiopathology*; D008991:Monitoring, Physiologic; D011247:Pregnancy; D019233:Retreatment; D018608:Ultrasonography, Doppler; D016216:Ultrasonography, Prenatal
Fischer R, Kuhlman K, Grover J, Montgomery O, Wapner R. Chronic, massive fetomaternal hemorrhage treated with repeated fetal intra-vascular transfusions. Am J Obstet Gynecol 1990;162:203–4.
Rouse D, Weiner C. Ongoing fetomaternal hemorrhage treated by serial intra-vascular transfusions. Obstet Gynecol 1990;76:974–5.
Thorp JA, Cohen GR, Yeast JD, Perryman D, Welsh C, Honssinger N, et al. Nonimmune hydrops caused by massive fetomaternal hemorrhage and treated by intra-vascular transfusion. Am J Perinatol 1992;9:22–4.
Kohlenberg C, Ellwood D. Fetomaternal haemorrhage treated with intra-vascular transfusion: a late complication of amniocentesis. Br J Obstet Gynaecol 1994;101:912–3.
Montgomery L, Belfort M, Adam K. Massive fetomaternal hemorrhage treated with serial intravascular and intraperitoneal fetal transfusions. Am J Obstet Gynecol 1995;173:234–5.
Hartung J, Chaoui R, Bollmann R. Nonimmune hydrops from fetomaternal hemorrhage treated with serial fetal intravascular transfusion. Obstet Gynecol 2000;96:844.
Rubod C, Houfflin V, Belot F, Ardiet E, Dufour P, Subtil D, et al. Successful in utero treatment of chronic and massive fetomaternal hemorrhage with fetal hydrops. Fetal Diagn Ther 2006;21:410–3.
Votino C, Mirlesse V, Gourand L, Parnet-Mathieu F, Bessières B, Daffos F. Successful treatment of a severe second trimester fetomaternal hemorrhage by repeated fetal intravascular transfusions. Fetal Diagn Ther 2008;24:503–5.
Mari G, Deter R, Carpenter R, Rahman F, Zimmerman R, Moise K, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000;342:9–14.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. Am J Obstet Gynecol 2006;195:1550–6.